Skip to content

Dr. Sabine Reeckmans

Active Private limited companyfounded 2010active for 16 yearsSchootstraat 46, 3550 Heusden-ZolderKBO/BCE: BE 0824.536.028

Lifetime

16 annual accounts with figures on one time axis
peak of €136,214 in 2024
€123,987▼ 9.0%
lowest -€3,838 in 2014
€72,339▼ 12.4%
peak of €427,314 in 2025
€427,314▲ 20.4%
€51,833▼ 28.0%
Board1 name since 2010
1 director
Documentsfilings and deeds
23-07-20268 days before the deadline
2025micro format
Equity from €354,975 to €427,314Debts from €71,957 to €51,833Cash from €22,562 to €31,020

Key points

from the 2025 annual accounts

Equity

€427,314 ▲ 20.4%

Dr. Sabine Reeckmans has made a profit without a break since 2015.

Turnover

≈ €220,000 estimated

The micro format states no turnover.

Position in the sector

89.2%

Higher solvency than 82% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as Dr. Sabine Reeckmans has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for Dr. Sabine Reeckmans. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 08-09-2023
  • 186 sharesdeed of 02-04-2010
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0824536028
changes role from statutory manager to statutory director reappointed as statutory director · Discharge granted to · General meeting of 08-09-2023 · Gazette deed
Incorporation Founding capital of €18,600, 186 shares, €12,400 paid up · Founded by (partner) · appointed as statutory manager · published on 02-04-2010 · Gazette deed
First establishment Schootstraat 46, Heusden-Zolder
All 29 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Sabine Reeckmans Heusden-Zolder €479,147 €123,987 89.2% -
Cabinet Medical du Docteur Anita Chanteux Herve €490,744 €121,335 80.1% -
Docteur Maud Materne Donceel €464,431 €126,170 95.5% -
MARVIL MEDIC Jemeppe-sur-Sambre €474,941 €119,734 92.4% -
MEDISCH KABINET Dr DECLEYRE PETER Meise €499,821 €121,811 43.1% -
CABINET DU DOCTEUR EN MEDECINE GENERALE JOSEPH CAPITAINE Ferrières €466,577 €128,655 93.8% -
HUISARTSPRAKTIJK DR. AMANT Temse €524,517 €124,249 95.1% -

These companies have the same main activity as Dr. Sabine Reeckmans: general medical practice (NACE 86210). They are comparable in size and age: total assets between €464,000 and €525,000, founded between 2009 and 2010.

Official details

Source: KBO
Status
Active since 31-03-2010Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment unit
2.186.805.6123550 Heusden-Zolder, since 31-03-2010
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

€479,147▲ 12.2%
Filing
Filed on 23-07-2026, 8 days before the end of the filing period
Financials

Insights on Dr. Sabine Reeckmans

Dr. Sabine Reeckmans files the micro format. That format states no turnover. The gross margin rose from €37,797 in 2010 to €123,987 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Sabine Reeckmans

What is the company number of Dr. Sabine Reeckmans?
The company number of Dr. Sabine Reeckmans is 0824.536.028. The VAT number is the same number with BE in front: BE 0824.536.028.
Where is Dr. Sabine Reeckmans based?
The registered office is at Schootstraat 46, 3550 Heusden-Zolder.Company details
What does Dr. Sabine Reeckmans do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Sabine Reeckmans?
Dr. Sabine Reeckmans is a private limited company (BV).
When was Dr. Sabine Reeckmans founded?
Dr. Sabine Reeckmans was founded on 31-03-2010.
Is Dr. Sabine Reeckmans still active?
Yes, Dr. Sabine Reeckmans is an active enterprise in the KBO register.
What is the turnover of Dr. Sabine Reeckmans?
The turnover in financial year 2025 is about €220,000. This figure is estimated from the gross margin of €123,987 and 30 comparable companies (NACE 86210). It probably lies between €180,000 and €280,000.Financials
Is Dr. Sabine Reeckmans profitable?
In financial year 2025, Dr. Sabine Reeckmans made a profit of €72,339.
Where can I find the annual accounts of Dr. Sabine Reeckmans?
Dr. Sabine Reeckmans filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Sabine Reeckmans due?
Dr. Sabine Reeckmans must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.